Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
Condition(s):Philadelphia Chromosome Positive CML; BCR-ABL Positive Chronic Myelogenous LeukemiaLast Updated:February 12, 2024Active, not recruiting